Illinois 101st Regular Session Status: Passed Senate

SB 3733 — INS-GENERIC PRESCRIPTION DRUGS

Last action — Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 101st Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2021 shall immediately substitute the brand name drug with the generic equivalent or move the brand name drug to a formulary tier that reduces an enrollee's cost. Grants rulemaking authority to the Department of Insurance. Defines "brand name drug", "generic drug", and "formulary". Effective January 1, 2021.

Bill Text

Action History

  1. Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020

  2. Rule 2-10 Third Reading/Passage Deadline Established As May 29, 2020

  3. Rule 2-10 Committee Deadline Established As May 22, 2020

  4. Rule 2-10 Third Reading/Passage Deadline Established As May 22, 2020

  5. Rule 2-10 Committee Deadline Established As May 15, 2020

  6. Rule 2-10 Third Reading/Passage Deadline Established As May 15, 2020

  7. Rule 2-10 Committee Deadline Established As May 7, 2020

  8. Rule 2-10 Committee Deadline Established As April 30, 2020

  9. Pursuant to Senate Rule 3-9(b) / Referred to Assignments

  10. Rule 2-10 Third Reading/Passage Deadline Established As May 7, 2020

  11. Rule 2-10 Committee Deadline Established As April 24, 2020

  12. Rule 2-10 Committee Deadline Established As April 2, 2020

  13. Assigned to Insurance

  14. Added as Chief Co-Sponsor Sen. Melinda Bush

  15. Referred to Assignments

  16. First Reading

  17. Filed with Secretary by Sen. Andy Manar

Sponsors

  • Andy Manar · Cosponsor
  • Melinda Bush · Cosponsor

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 2 co-sponsors · 181 not signed on

Sponsors (0)

None.

Co-sponsors (2)

  • Andy Manar
  • Melinda Bush

Not signed on (181)

181 members have not signed on to this bill.

Show all 181 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 3733 do?
Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2021 shall immediately substitute the brand name drug with the generic equivalent or move the brand name drug to a formulary tier that reduces an enrollee's cost. Grants rulemaking authority to the Department of Insurance. Defines "brand name drug", "generic drug", and "formulary". Effective January 1, 2021.
Who sponsors SB 3733?
SB 3733 is sponsored by Andy Manar and Melinda Bush.
What is the current status of SB 3733?
This bill died with 101st Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 3733?
Track SB 3733 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 3733

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 3733

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →